These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20815986)

  • 1. [Inhibitor of apoptosis in lung cancer Livin perioperative clinical research].
    Wang LN; Mou J; Zhang YB; Dong P; Diao X; Wang SY; Chen H; Liu YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):889-90. PubMed ID: 20815986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of expressions of tumor markers in peripheral blood in non-small cell lung cancer].
    Qu YM; Liao GQ; Liu PH; Wang HM; Liu L; Li LL; Xie GQ
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1958-62. PubMed ID: 20979858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
    Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
    Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
    Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.
    Crnković-Mertens I; Muley T; Meister M; Hartenstein B; Semzow J; Butz K; Hoppe-Seyler F
    Lung Cancer; 2006 Nov; 54(2):135-42. PubMed ID: 16965834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Szydlik S; Leśniewska K; Krzyzanowski M
    Przegl Lek; 2006; 63(10):936-40. PubMed ID: 17288188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival.
    Xi RC; Biao WS; Gang ZZ
    Onkologie; 2011; 34(8-9):428-32. PubMed ID: 21934342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis.
    Takahashi H; Kurishima K; Ishikawa H; Kagohashi K; Kawaguchi M; Satoh H
    Anticancer Res; 2010 Sep; 30(9):3833-7. PubMed ID: 20944179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients.
    De Vita F; Orditura M; Auriemma A; Infusino S; Catalano G
    J Exp Clin Cancer Res; 1998 Dec; 17(4):413-7. PubMed ID: 10089060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.